Scientists showed that psVEGFR‐3 significantly diminished cell growth with and without added VEGF‐C in vitro, and significantly reduced primary tumor growth and tumor metastases to wide‐spectrum organs in vivo.
[Cancer Science]
1254621
IZGISKVH
items
1
apa
0
default
asc
1
151243
https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3A%22zotpress-c8ba5e51e885fa380cf61cc6f04d2005%22%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22IZGISKVH%22%2C%22library%22%3A%7B%22id%22%3A1254621%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Shibata%20et%20al.%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EShibata%2C%20M.-A.%2C%20Shibata%2C%20E.%2C%20Tanaka%2C%20Y.%2C%20Shiraoka%2C%20C.%2C%20%26amp%3B%20Kondo%2C%20Y.%20%28n.d.%29.%20Soluble%20Vegfr3%20gene%20therapy%20suppresses%20multi-organ%20metastasis%20in%20a%20mouse%20mammary%20cancer%20model.%20%3Ci%3ECancer%20Science%3C%5C%2Fi%3E%2C%20%3Ci%3En%5C%2Fa%3C%5C%2Fi%3E%28n%5C%2Fa%29.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1111%5C%2Fcas.14531%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1111%5C%2Fcas.14531%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.stemcellsciencenews.com%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D1254621%26amp%3Bitem_key%3DIZGISKVH%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Soluble%20Vegfr3%20gene%20therapy%20suppresses%20multi-organ%20metastasis%20in%20a%20mouse%20mammary%20cancer%20model%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Masa-Aki%22%2C%22lastName%22%3A%22Shibata%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eiko%22%2C%22lastName%22%3A%22Shibata%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yoshihisa%22%2C%22lastName%22%3A%22Tanaka%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chinatsu%22%2C%22lastName%22%3A%22Shiraoka%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yoichi%22%2C%22lastName%22%3A%22Kondo%22%7D%5D%2C%22abstractNote%22%3A%22Accumulating%20evidence%20on%20the%20association%20of%20VEGF-C%20with%20lymphangiogenesis%20and%20lymph%20node%20metastasis%20implicates%20lymphatic%20vessels%20as%20a%20potential%20target%20in%20anti-cancer%20therapy.%20To%20evaluate%20whether%20blocking%20VEGF-C%20and%20VEGFR-3%20signaling%20can%20inhibit%20multi-organ%20metastases%2C%20a%20mouse%20metastatic%20mammary%20cancer%20model%20was%20subjected%20to%20gene%20therapy%20using%20a%20soluble%20VEGFR-3%20expression%20vector%20%28psVEGFR-3%29.%20We%20showed%20that%20psVEGFR-3%20significantly%20diminished%20cell%20growth%20with%20and%20without%20added%20VEGF-C%20in%20vitro%2C%20and%20significantly%20reduced%20primary%20tumor%20growth%20and%20tumor%20metastases%20to%20wide-spectrum%20organs%20in%20vivo.%20Although%20apoptotic%20cell%20death%20and%20angiogenesis%20levels%20did%20not%20differ%20between%20the%20control%20and%20psVEGFR-3%20groups%2C%20cell%20proliferation%20and%20lymphangiogenesis%20in%20the%20mammary%20tumors%20were%20significantly%20decreased%20in%20the%20psVEGFR-3%20group.%20Furthermore%2C%20lymphatic%20vessel%20invasion%20was%20significantly%20inhibited%20in%20this%20group.%20Real-time%20RT-PCR%20analysis%20revealed%20significantly%20high%20expression%20of%20the%20Vegfr3%20gene%20owing%20to%20gene%20therapy%2C%20and%20the%20transcriptional%20levels%20of%20Pcna%20and%20Lyve1%20tended%20to%20decrease%20in%20the%20psVEGFR-3%20group.%20Immunofluorescence%20staining%20indicated%20that%20phospho-tyrosine%20expression%20was%20considerably%20lower%20in%20tumor%20cells%20of%20psVEGFR-3-treated%20mammary%20carcinomas%20than%20those%20of%20control%20tumors.%20Double%20immunofluorescence%20staining%20indicated%20that%20phospho-tyrosine%2B%5C%2FLYVE-1%2B%20%28a%20lymphatic%20vessel%20marker%29%20tended%20to%20decrease%20in%20psVEGFR-3-treated%20mammary%20carcinomas%20compared%20with%20control%20mice%2C%20indicating%20a%20decline%20in%20the%20activity%20of%20the%20VEGF-C%5C%2FVEGFR-3%20axis.%20These%20findings%20showed%20that%20a%20blockade%20of%20VEGF-C%5C%2FVEGFR-3%20signaling%20caused%20by%20sVEGFR-3%20sequestered%20VEGF-C%20and%20prevented%20the%20side-effects%20of%20anti-angiogenesis%20and%20suppressed%20overall%20metastases%2C%20suggesting%20their%20high%20clinical%20significance.%22%2C%22date%22%3A%22%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1111%5C%2Fcas.14531%22%2C%22ISSN%22%3A%221349-7006%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fonlinelibrary.wiley.com%5C%2Fdoi%5C%2Fabs%5C%2F10.1111%5C%2Fcas.14531%22%2C%22deleted%22%3A1%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222020-06-29T18%3A54%3A55Z%22%7D%7D%5D%7D
Shibata, M.-A., Shibata, E., Tanaka, Y., Shiraoka, C., & Kondo, Y. (n.d.). Soluble Vegfr3 gene therapy suppresses multi-organ metastasis in a mouse mammary cancer model. Cancer Science, n/a(n/a). https://doi.org/10.1111/cas.14531 Cite
